Evidence map›Paper›PMID 35064132›Full record

ArticleScientific reports2022

Targeted isolation of photoactive pigments from mushrooms yielded a highly potent new photosensitizer: 7,7'-biphyscion.

Fabian Hammerle, Isabella Bingger, Andrea Pannwitz, Alexander Magnutzki, Ronald Gstir, Adriano Rutz, Jean-Luc Wolfender, Ursula Peintner, Bianka Siewert

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
1.8field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 16 citations in OpenAlex.

  1. Revised taxon definition in EuropeanMycological progress · 2024
    Article
  2. Ruthenium-Based Photoactivated Chemotherapy.Journal of the American Chemical Society · 2023
    Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Optimized isolation of 7,7'-biphyscion starting from Cortinarius rubrophyllus, a chemically unexplored fungal species rich in photosensitizers.Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology · 2022
    Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 5 institutions in 3 countries.

Fabian HammerleInstitute of Pharmacy/Pharmacognosy and Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, Innrain 80-82, 6020, Innsbruck, Austria.
Isabella BinggerDepartment of Biotechnology, MCI Management Center Innsbruck, 6020, Innsbruck, Austria.
Andrea PannwitzLeiden Institute of Chemistry, Gorlaeus Laboratories, Leiden University, P.O Box 9502, 2300 RA, Leiden, The Netherlands.
Alexander MagnutzkiAustrian Drug Screening Institute GmbH (ADSI) and Institute of Analytical and Radiochemistry, University of Innsbruck, Innrain 80-82, 6020, Innsbruck, Austria.
Ronald GstirAustrian Drug Screening Institute GmbH (ADSI) and Institute of Analytical and Radiochemistry, University of Innsbruck, Innrain 80-82, 6020, Innsbruck, Austria.
Adriano RutzSchool of Pharmaceutical Sciences, University of Geneva, CMU-Rue Michel-Servet 1, 1211, Geneva 4, Switzerland.
Jean-Luc WolfenderSchool of Pharmaceutical Sciences, University of Geneva, CMU-Rue Michel-Servet 1, 1211, Geneva 4, Switzerland.
Ursula PeintnerInstitute of Microbiology, University of Innsbruck, Technikerstraße 25, 6020, Innsbruck, Austria.
Bianka SiewertInstitute of Pharmacy/Pharmacognosy and Center for Molecular Biosciences Innsbruck (CMBI), University of Innsbruck, Innrain 80-82, 6020, Innsbruck, Austria. bianka.siewert@uibk.ac.at.
Universität Innsbruck · ATUniversity of Geneva · CHAustrian Drug Screening Institute (Austria) · ATLeiden University · NLManagement Center Innsbruck · AT

Funding

Austrian Science Fund P31915Austrian Science Fund FWF P 31915Austrian Science Fund FWF P 31950
6 · The paper itself

Abstract

Pigments of fungi are a fertile ground of inspiration: they spread across various chemical backbones, absorption ranges, and bioactivities. However, basidiomycetes with strikingly colored fruiting bodies have never been explored as agents for photodynamic therapy (PDT), even though known photoactive compound classes (e.g., anthraquinones or alkaloids) are used as chemotaxonomic markers. In this study, we tested the hypothesis that the dyes of skin-heads (dermocyboid Cortinarii) can produce singlet oxygen under irradiation and thus are natural photosensitizers. Three photosensitizers based on anthraquinone structures were isolated and photopharmaceutical tests were conducted. For one of the three, i.e., (-)-7,7'-biphyscion (1), a promising photoyield and photocytotoxicity of EC

Indexed as

A549 CellsAnthraquinonesCortinariusHeLa CellsHumansLightPhotosensitizing AgentsSinglet Oxygen7,7'-biphyscionAnthraquinonesPhotosensitizing AgentsSinglet Oxygen

Identifiers

PMID35064132
PMCPMC8782903
OpenAlexW4205676016

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.